|
|
||||||||
1 1st Department of Medicine, Johannes Gutenberg University of Mainz, D-55101 Mainz, Germany
and2 Liver Research Center, Albert Einstein College of Medicine, Bronx, New York, U.S.A.
As a putative mechanism of hepatitis B virus (HBV) uptake into hepatocytes the interaction between HBV and the hepatic, human-derived asialoglycoprotein receptor (ASGPR) was investigated. Sera from patients with different variations of hepatitis B surface antigen-(HBsAg) positive chronic hepatitis, HBV particles isolated from HBV carriers with high-titre viraemia and commercial HBsAg served as sources of HBV. ASGPR was affinity-purified from human liver. HBV that had bound to isolated ASGPR was either detected by radio-immunoassay using solid-phase bound ASGPR or enzyme immunoassay with biotin-ASGPR bound to immobilized HBV. Furthermore, binding and uptake of purified, 125I-labelled HBV particles into human hepatoma cell lines (HepG2 and HuH7), which constitutively express functional ASGPR molecules, were compared to that of ASGPR-negative COS cells. As a result HBV was found to bind to purified human ASGPR in two different assays. Circulating virus particles from sera with high titre viraemia showed the highest attachment activity to ASGPR. HBV binding to purified ASGPR was saturable and inhibitable by an excess of D-galactose-bearing ligands, by EDTA and anti-receptor immunoglobulin. Lysis of particles by adding detergent abolished immunodetectable HBV binding to purified ASGPR. Commercial HBsAg did not adhere to solid phase-immobilized ASGPR. Monoclonal anti-preS1 antibody (MA18/7) but not anti-preS2 antibody (Q19/10) inhibited virus attachment. Purified and radiolabelled HBV particles showed binding to HepG2 and HuH7 cells but to much lesser degree to COS cells. Cellular binding of HBV was significantly inhibited by blocking of ASGPR function. Both ASGPR ligands and rabbit anti-ASGPR immunoglobulin but not non-immune rabbit serum inhibited uptake of radiolabelled HBV particles into HepG2 cells or HuH7 cells, respectively. This study suggests that HBV virions may enter human hepatocytes via ASGPR molecules by attachment of viral preS1-related envelope binding sites to this receptor.
Received 1 March 1994;
accepted 5 May 1994.
This article has been cited by other articles:
![]() |
Q. Deng, J.-w. Zhai, M.-L. Michel, J. Zhang, J. Qin, Y.-y. Kong, X.-x. Zhang, A. Budkowska, P. Tiollais, Y. Wang, et al. Identification and Characterization of Peptides That Interact with Hepatitis B Virus via the Putative Receptor Binding Site J. Virol., April 15, 2007; 81(8): 4244 - 4254. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Vanlandschoot, F. Van Houtte, A. Roobrouck, A. Farhoudi, F. Stelter, D. L. Peterson, J. Gomez-Gutierrez, F. Gavilanes, and G. Leroux-Roels LPS-binding protein and CD14-dependent attachment of hepatitis B surface antigen to monocytes is determined by the phospholipid moiety of the particles J. Gen. Virol., September 1, 2002; 83(9): 2279 - 2289. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Dotzauer, U. Gebhardt, K. Bieback, U. Göttke, A. Kracke, J. Mages, S. M. Lemon, and A. Vallbracht Hepatitis A Virus-Specific Immunoglobulin A Mediates Infection of Hepatocytes with Hepatitis A Virus via the Asialoglycoprotein Receptor J. Virol., December 1, 2000; 74(23): 10950 - 10957. [Abstract] [Full Text] |
||||
![]() |
C. J. Ryu, D.-Y. Cho, P. Gripon, H. S. Kim, C. Guguen-Guillouzo, and H. J. Hong An 80-Kilodalton Protein That Binds to the Pre-S1 Domain of Hepatitis B Virus J. Virol., January 1, 2000; 74(1): 110 - 116. [Abstract] [Full Text] |
||||
![]() |
L. A. de la Vega and R. J. Stockert The Cytoplasmic Coatomer Protein COPI. A POTENTIAL TRANSLATIONAL REGULATOR J. Biol. Chem., October 29, 1999; 274(44): 31135 - 31138. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Harvey, T. Macnaughton, D. Park, and E. Gowans A cellular protein which binds hepatitis B virus but not hepatitis B surface antigen J. Gen. Virol., March 1, 1999; 80(3): 607 - 615. [Abstract] |
||||
![]() |
R. J. Stockert and Q. Ren Cytoplasmic Protein mRNA Interaction Mediates cGMP-modulated Translational Control of the Asialoglycoprotein Receptor J. Biol. Chem., April 4, 1997; 272(14): 9161 - 9165. [Abstract] [Full Text] [PDF] |
||||
![]() |
R.-i. Tozawa, S. Ishibashi, J.-i. Osuga, K. Yamamoto, H. Yagyu, K. Ohashi, Y. Tamura, N. Yahagi, Y. Iizuka, H. Okazaki, et al. Asialoglycoprotein Receptor Deficiency in Mice Lacking the Major Receptor Subunit. ITS OBLIGATE REQUIREMENT FOR THE STABLE EXPRESSION OF OLIGOMERIC RECEPTOR J. Biol. Chem., April 13, 2001; 276(16): 12624 - 12628. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. C. N. Rensen, L. A. J. M. Sliedregt, M. Ferns, E. Kieviet, S. M. W. van Rossenberg, S. H. van Leeuwen, T. J. C. van Berkel, and E. A. L. Biessen Determination of the Upper Size Limit for Uptake and Processing of Ligands by the Asialoglycoprotein Receptor on Hepatocytes in Vitro and in Vivo J. Biol. Chem., September 28, 2001; 276(40): 37577 - 37584. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. De Falco, M. G. Ruvoletto, A. Verdoliva, M. Ruvo, A. Raucci, M. Marino, S. Senatore, G. Cassani, A. Alberti, P. Pontisso, et al. Cloning and Expression of a Novel Hepatitis B Virus-binding Protein from HepG2 Cells J. Biol. Chem., September 21, 2001; 276(39): 36613 - 36623. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | MICROBIOLOGY | J GEN VIROL |
| J MED MICROBIOL | ALL SGM JOURNALS | |